Tang Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Tang Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$114M	Sell	3,785,991 -135,228	-3%	-$4.48M	5.77%	4
2025 Q4	$128M	Sell	3,921,219 -229,975	-6%	-$7.43M	6.33%	2
2025 Q3	$144M	Buy	4,151,194 +161,083	+4%	+$5.15M	5.54%	2
2025 Q2	$112M	Buy	3,990,111 +28,314	+0.7%	+$759K	5.65%	1
2025 Q1	$99.5M	Buy	3,961,797 +1,800,597	+83%	+$45.5M	5.51%	2
2024 Q4	$59.4M	Buy	2,161,200 +1,461,200	+209%	+$40.7M	3.93%	3
2024 Q3	$20.2M	Buy	700,000 +644,391	+1,159%	+$17.5M	1.44%	19
2024 Q2	$1.38M	Buy	+55,609	New	+$1.58M	0.14%	85
2023 Q4	–	Sell	-89,650	Closed	-$3.1M	–	127
2023 Q3	$3.1M	Hold	89,650	–	–	0.44%	59
2023 Q2	$3.65M	Hold	89,650	–	–	0.54%	51
2023 Q1	$3.46M	Sell	89,650 -25,300	-22%	-$1.04M	0.52%	49
2022 Q4	$5.1M	Sell	114,950 -110,000	-49%	-$4.63M	0.74%	35
2022 Q3	$9.59M	Sell	224,950 -25,050	-10%	-$1.28M	1.18%	24
2022 Q2	$13.9M	Hold	250,000	–	–	2.12%	16
2022 Q1	$15.5M	Buy	+250,000	New	+$15.3M	3.1%	9

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tang Capital Management's LKFT Position: Q1 2026 in Review

Tang Capital Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 3.4% in Q1 2026, selling an estimated $4.48M and leaving 3,785,991 shares worth $114M. The position accounts for 5.77% of the portfolio, ranked #4.

Tang Capital Management first reported a position in LKFT in Q1 2022 and has held it in 15 quarters since. The position peaked at $144M in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Tang Capital Management held 3,785,991 shares of Lakefront Biotherapeutics American Depositary Shares worth $114M as of Q1 2026.
Tang Capital Management sold 135,228 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $4.48M.
Lakefront Biotherapeutics American Depositary Shares made up 5.77% of Tang Capital Management's portfolio in Q1 2026, its #4 holding.
Tang Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2022 and has held it in 15 quarters since.
Tang Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $144M in Q3 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.